Since 2001, the Abigail Alliance has fought for wider access to experimental treatments. We are a 501(c)(3) that advocates for people with life-threatening illnesses.

Monday, September 16, 2019

Sharpless may seal FDA commissioner nomination before November deadline


After orchestrating a series of moves to help cancer patients, the FDA’s acting commissioner appears to be on the inside track for a permanent appointment to the post


Wednesday, August 7, 2019

FDA holds groundbreaking meeting to discuss accelerating promising treatments


A new, influential patient advocacy group brought together senior FDA leadership and a biotechnology company to accelerate ALS research


Wednesday, June 19, 2019

After massive protests, ALS Association speaks out against controversial researcher


The ALS Association (ALSA) is distancing itself from a researchers who is mired in controversy